PAS
SGMO

Point72 Asia (Singapore)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Point72 Asia (Singapore)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$24 Hold
35
– – ﹤0.01% 847
2025
Q2 		$19 Sell
35
-72,303
-100% -$42.9K ﹤0.01% 846
2025
Q1 		$47.4K Buy
72,338
+21,139
+41% +$22.4K 0.01% 580
2024
Q4 		$52.2K Sell
51,199
-57,678
-53% -$105K 0.01% 502
2024
Q3 		$94.3K Sell
108,877
-138,989
-56% -$102K 0.02% 556
2024
Q2 		$88.8K Buy
+247,866
New +$134K 0.02% 519

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Point72 Asia (Singapore)'s SGMO Position: Q3 2025 in Review

Point72 Asia (Singapore) held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2025 at 35 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Point72 Asia (Singapore) first reported a position in SGMO in Q2 2024 and has held it in 6 quarters since. The position peaked at $94.3K in Q3 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

  • Point72 Asia (Singapore) held 35 shares of SANGAMO THERAPEUTICS INC worth $24 as of Q3 2025.
  • Point72 Asia (Singapore) left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2025.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #847 holding.
  • Point72 Asia (Singapore) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and has held it in 6 quarters since.
  • Point72 Asia (Singapore)'s SANGAMO THERAPEUTICS INC position peaked at $94.3K in Q3 2024.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.